CiSTEM = Clinical immunology + STEM


CiSTEM conducts clinical immunology & stem cell research
and aims to proceed induced pluripotent stem cell research and develop therapeutics based on our research.

Induced pluripotent stem cells have self-replicating ability and pluripotency.
Therefore, extensive research using iPSCs is currently underway worldwide.

CiSTEM provides a induced pluripotent stem cell line production service tailored to clients,
and provides quality verification through advanced characterization.


  • 05

    Start-up leap forward package support project (KISED)

  • 05

    Commercialization support project of BIG 3 innovation field start-up package (KIAT)

  • 04

    Headquarter expansion and relocation (47-3 Banpo-daero 39-gil, Seocho-gu, Seoul)


  • 12

    Patent transfer contract and technology transfer between The Catholic University Industry-Academic Cooperation Foundation and CiSTEM

  • 11

    Catholic Master Cell, the first clinical trial for osteoarthritis patients

  • 10

    Won “Best Award” at 2019 Anti-Aging Health Startup Fair hosted by Korea Economic Daily

  • 10

    Awarded for contributing to commercialization of health and medical technology Awarded by KHIDI

  • 09

    Initial start-up package business order

  • 05

    Signed a joint development contract with T&R Biofab and CiSTEM for treatment of rare immune diseases

  • 03

    Innovative startup member business of KHIDI


  • 12

    Patent for systemic sclerosis disease model and its use (application number 10-2019-0177114, PCT/KR2019/018654)

  • 06

    Patent on a method for producing a pellet of chondrocytes from human induced pluripotent stem cells and its use (application number 10-2018-0072875)

  • 01

    Patent registration of chondrocytes induced differentiation using separation by cell size through centrifugation (Registration No. 10-2014020)


  • 12

    Patent for a method of manufacturing a composition for differentiation of chondrocytes using human pluripotent cells derived from umbilical cord blood mononuclear cells of HLA homozygous (Registration No.: 10-2030906)

  • 02

    Founded CiSTEM Co., Ltd. located in Catholic University, 222 Banpo-daero, Seocho-gu, Seoul


  • 03

    Catholic iPSC Research Center (CiRC) Established Induced Pluripotent Stem Cell Application Research Center under the Catholic University of Korea


  • 03

    Established CiSTEM laboratory